Product information

From Health Canada

Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):
Market status:
Not Marketed
Licence Status:
Brand name(s):
NutraSea® Dry Eye Targeted Omega-3 ;
NutraSea Dry Eye ;
NutraSea Dry Eye Softgels ;
NutraSea Dry Eye Targeted Omega-3 Softgels ;
NutraSea Targeted Dry Eye
Licence holder:
Nature's Way of Canada Ltd.
Dosage Form:
Capsule, soft
Recommended route of administration:


Recommended dose:
Sub population (Sub Pop.) Quantity (Qty) Frequency (Freq.)
Sub Pop. Age Min. Max. UoM Footnote1 Age Qty Min. Max. UoM Qty Freq. Min. Max. UoM Freq.
Adults and Adolescents 14 year(s) 2.0 capsule 2 day
Recommended use or purpose:
Source of omega-3 fatty acids for the maintenance of good health. Helps support cognitive health and/or brain function. Helps relieve symptoms of Dry Eye Syndrome. Helps improve symptoms of Dry Eye Syndrome. Helps provide relief/improve symptoms of dry eye syndrome including support for proper tear function (decreased rate of tear evaporation and increase in tear secretion). Helps support proper tear function in persons with Dry Eye Syndrome. Helps decrease the rate of tear evaporation in persons with Dry Eye Syndrome. Helps increase tear secretion in persons with Dry Eye Syndrome.
Risk Information:
Cautions and Warnings 
If symptoms of dry eyes worsen, consult a health care practitioner.
List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Potency
Borago officinalis 145.4 milligrams
24.5   milligrams
Gamma-Linolenic acid
Fish oil 0.7 Grams
300.0   milligrams
Eicosapentaenoic acid
75.0   milligrams
Docosahexaenoic acid
Oenothera biennis 145.4 milligrams
13.0   milligrams
Gamma-Linolenic acid
List of non-medicinal ingredients:
  • Gelatin
  • Glycerin
  • Mint Flavour
  • Purified water
  • Rosmarinus Officinalis (Rosemary) Leaf Extract
  • Tocopherols
Date of licensing:
Revised date of licence:

Application information

Related information

Compendium of monographs

Contact us

For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).

Date modified: